GlassScriptPhysician profile
Erik S Kramer
NPI 1215298062
$10,774.19
in general payments reported to CMS, 2019-2025
10 companies · $5,142 in 2025
The $5,142 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2021: $20.25 · 2022: $324 · 2023: $575 · 2024: $4,595 · 2025: $5,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,488 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,632 · Food and Beverage: $1,747 · Travel and Lodging: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,487.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,632.00 |
| Food and Beverage | $1,747.33 |
| Travel and Lodging | $444.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $5,595.19 | 2024-2025 | Omnipod, Omnipod |
| Dexcom, INC. | $3,340.66 | 2024 | Dexcom Stelo Glucose Biosensor |
| Novo Nordisk INC | $780.18 | 2022-2025 | Wegovy |
| Genzyme Corporation | $468.46 | 2019-2025 | |
| Rhythm Pharmaceuticals, INC. | $246.82 | 2023-2024 | Imcivree, Imcivree |
| Beta Bionics, INC. | $196.79 | 2024 | Ilet Bionic Pancreas |
| Chiesi USA, INC. | $112.11 | 2025 | Myalept |
| Abbott Laboratories | $18.13 | 2024 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $15.85 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.